IBDEI12L ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,18884,1,4,0)
 ;;=4^266.1
 ;;^UTILITY(U,$J,358.3,18884,1,5,0)
 ;;=5^Vitamin B6 Deficiency
 ;;^UTILITY(U,$J,358.3,18884,2)
 ;;=^101683
 ;;^UTILITY(U,$J,358.3,18885,0)
 ;;=780.99^^105^1223^3
 ;;^UTILITY(U,$J,358.3,18885,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18885,1,4,0)
 ;;=4^780.99
 ;;^UTILITY(U,$J,358.3,18885,1,5,0)
 ;;=5^Cold Intolerance
 ;;^UTILITY(U,$J,358.3,18885,2)
 ;;=Cold Intolerance^328568
 ;;^UTILITY(U,$J,358.3,18886,0)
 ;;=255.41^^105^1223^1
 ;;^UTILITY(U,$J,358.3,18886,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18886,1,4,0)
 ;;=4^255.41
 ;;^UTILITY(U,$J,358.3,18886,1,5,0)
 ;;=5^Adrenal Insuff
 ;;^UTILITY(U,$J,358.3,18886,2)
 ;;=^335240
 ;;^UTILITY(U,$J,358.3,18887,0)
 ;;=249.00^^105^1223^49
 ;;^UTILITY(U,$J,358.3,18887,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18887,1,4,0)
 ;;=4^249.00
 ;;^UTILITY(U,$J,358.3,18887,1,5,0)
 ;;=5^Secondary DM w/o Complication
 ;;^UTILITY(U,$J,358.3,18887,2)
 ;;=^336728
 ;;^UTILITY(U,$J,358.3,18888,0)
 ;;=249.40^^105^1223^48
 ;;^UTILITY(U,$J,358.3,18888,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18888,1,4,0)
 ;;=4^249.40
 ;;^UTILITY(U,$J,358.3,18888,1,5,0)
 ;;=5^Secondary DM w/ Renal Complications
 ;;^UTILITY(U,$J,358.3,18888,2)
 ;;=^336732
 ;;^UTILITY(U,$J,358.3,18889,0)
 ;;=249.60^^105^1223^47
 ;;^UTILITY(U,$J,358.3,18889,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18889,1,4,0)
 ;;=4^249.60
 ;;^UTILITY(U,$J,358.3,18889,1,5,0)
 ;;=5^Secondary DM w/ Neuro Complications
 ;;^UTILITY(U,$J,358.3,18889,2)
 ;;=^336734
 ;;^UTILITY(U,$J,358.3,18890,0)
 ;;=257.2^^105^1223^31
 ;;^UTILITY(U,$J,358.3,18890,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18890,1,4,0)
 ;;=4^257.2
 ;;^UTILITY(U,$J,358.3,18890,1,5,0)
 ;;=5^Hypogonadism
 ;;^UTILITY(U,$J,358.3,18890,2)
 ;;=^88213
 ;;^UTILITY(U,$J,358.3,18891,0)
 ;;=255.42^^105^1223^38
 ;;^UTILITY(U,$J,358.3,18891,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18891,1,4,0)
 ;;=4^255.42
 ;;^UTILITY(U,$J,358.3,18891,1,5,0)
 ;;=5^Mineralcorticoid Deficient
 ;;^UTILITY(U,$J,358.3,18891,2)
 ;;=^335241
 ;;^UTILITY(U,$J,358.3,18892,0)
 ;;=259.50^^105^1223^2
 ;;^UTILITY(U,$J,358.3,18892,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18892,1,4,0)
 ;;=4^259.50
 ;;^UTILITY(U,$J,358.3,18892,1,5,0)
 ;;=5^Androgen Insensitivity,Unspec
 ;;^UTILITY(U,$J,358.3,18892,2)
 ;;=^336738
 ;;^UTILITY(U,$J,358.3,18893,0)
 ;;=275.5^^105^1223^18
 ;;^UTILITY(U,$J,358.3,18893,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18893,1,4,0)
 ;;=4^275.5
 ;;^UTILITY(U,$J,358.3,18893,1,5,0)
 ;;=5^Hungry Bone Syndrome
 ;;^UTILITY(U,$J,358.3,18893,2)
 ;;=^336538
 ;;^UTILITY(U,$J,358.3,18894,0)
 ;;=793.2^^105^1224^3
 ;;^UTILITY(U,$J,358.3,18894,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18894,1,4,0)
 ;;=4^793.2
 ;;^UTILITY(U,$J,358.3,18894,1,5,0)
 ;;=5^Abnormal Chest x-ray, other
 ;;^UTILITY(U,$J,358.3,18894,2)
 ;;=^273419
 ;;^UTILITY(U,$J,358.3,18895,0)
 ;;=277.6^^105^1224^5
 ;;^UTILITY(U,$J,358.3,18895,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18895,1,4,0)
 ;;=4^277.6
 ;;^UTILITY(U,$J,358.3,18895,1,5,0)
 ;;=5^Alpha-1 antitrypsin deficiency
 ;;^UTILITY(U,$J,358.3,18895,2)
 ;;=^87463
 ;;^UTILITY(U,$J,358.3,18896,0)
 ;;=493.92^^105^1224^6
 ;;^UTILITY(U,$J,358.3,18896,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18896,1,4,0)
 ;;=4^493.92
 ;;^UTILITY(U,$J,358.3,18896,1,5,0)
 ;;=5^Asthma, Acute Exacerbation
 ;;^UTILITY(U,$J,358.3,18896,2)
 ;;=^322001
 ;;^UTILITY(U,$J,358.3,18897,0)
 ;;=493.20^^105^1224^11
 ;;^UTILITY(U,$J,358.3,18897,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18897,1,4,0)
 ;;=4^493.20
 ;;^UTILITY(U,$J,358.3,18897,1,5,0)
 ;;=5^COPD with Asthma
 ;;
 ;;$END ROU IBDEI12L
